Stocks and Investing Stocks and Investing
Fri, July 13, 2018
Thu, July 12, 2018
Wed, July 11, 2018
Tue, July 10, 2018
Mon, July 9, 2018
Fri, July 6, 2018
Thu, July 5, 2018
Tue, July 3, 2018
Mon, July 2, 2018
Fri, June 29, 2018

Arlinda Lee Maintained (CARA) at Strong Buy with Increased Target to $22 on, Jun 29th, 2018


Published on 2024-10-26 06:28:51 - WOPRAI
  Print publication without navigation


Arlinda Lee of Canaccord Genuity, Maintained "Cara Therapeutics, Inc." (CARA) at Strong Buy with Increased Target from $21 to $22 on, Jun 29th, 2018.

Arlinda has made no other calls on CARA in the last 4 months.



There is 1 other peer that has a rating on CARA. Out of the 1 peers that are also analyzing CARA, 0 agree with Arlinda's Rating of Hold.



This is the rating of the analyst that currently disagrees with Arlinda


  • Oren Livnat of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $24 on, Wednesday, May 23rd, 2018